Global Synthetic Lethality-based Drugs and Targets Market Size, Status and Forecast 2020-2026

Global Synthetic Lethality-based Drugs and Targets Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Synthetic Lethality-based Drugs and Targets Revenue
1.4 Market Analysis by Type
1.4.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2020 VS 2026
1.5.2 Medical Research Institution
1.5.3 Hospital and Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Synthetic Lethality-based Drugs and Targets Market Perspective (2015-2026)
2.2 Synthetic Lethality-based Drugs and Targets Growth Trends by Regions
2.2.1 Synthetic Lethality-based Drugs and Targets Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Synthetic Lethality-based Drugs and Targets Historic Market Share by Regions (2015-2020)
2.2.3 Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Synthetic Lethality-based Drugs and Targets Market Growth Strategy
2.3.6 Primary Interviews with Key Synthetic Lethality-based Drugs and Targets Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Market Size
3.1.1 Global Top Synthetic Lethality-based Drugs and Targets Players by Revenue (2015-2020)
3.1.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Players (2015-2020)
3.1.3 Global Synthetic Lethality-based Drugs and Targets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio
3.2.1 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Synthetic Lethality-based Drugs and Targets Revenue in 2019
3.3 Synthetic Lethality-based Drugs and Targets Key Players Head office and Area Served
3.4 Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
3.5 Date of Enter into Synthetic Lethality-based Drugs and Targets Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Type (2015-2020)
4.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2021-2026)
5 Synthetic Lethality-based Drugs and Targets Breakdown Data by Application (2015-2026)
5.1 Global Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020)
5.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Synthetic Lethality-based Drugs and Targets Market Size (2015-2020)
6.2 Synthetic Lethality-based Drugs and Targets Key Players in North America (2019-2020)
6.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020)
6.4 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020)
7 Europe
7.1 Europe Synthetic Lethality-based Drugs and Targets Market Size (2015-2020)
7.2 Synthetic Lethality-based Drugs and Targets Key Players in Europe (2019-2020)
7.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020)
7.4 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020)
8 China
8.1 China Synthetic Lethality-based Drugs and Targets Market Size (2015-2020)
8.2 Synthetic Lethality-based Drugs and Targets Key Players in China (2019-2020)
8.3 China Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020)
8.4 China Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020)
9 Japan
9.1 Japan Synthetic Lethality-based Drugs and Targets Market Size (2015-2020)
9.2 Synthetic Lethality-based Drugs and Targets Key Players in Japan (2019-2020)
9.3 Japan Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020)
9.4 Japan Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size (2015-2020)
10.2 Synthetic Lethality-based Drugs and Targets Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020)
10.4 Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020)
11 India
11.1 India Synthetic Lethality-based Drugs and Targets Market Size (2015-2020)
11.2 Synthetic Lethality-based Drugs and Targets Key Players in India (2019-2020)
11.3 India Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020)
11.4 India Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Synthetic Lethality-based Drugs and Targets Market Size (2015-2020)
12.2 Synthetic Lethality-based Drugs and Targets Key Players in Central & South America (2019-2020)
12.3 Central & South America Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020)
12.4 Central & South America Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020)
13Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview and Its Total Revenue
13.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Introduction
13.1.4 AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview and Its Total Revenue
13.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Introduction
13.2.4 AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 BeiGene
13.3.1 BeiGene Company Details
13.3.2 BeiGene Business Overview and Its Total Revenue
13.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Introduction
13.3.4 BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
13.3.5 BeiGene Recent Development
13.4 Clovis Oncology
13.4.1 Clovis Oncology Company Details
13.4.2 Clovis Oncology Business Overview and Its Total Revenue
13.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Introduction
13.4.4 Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
13.4.5 Clovis Oncology Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Introduction
13.5.4 GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview and Its Total Revenue
13.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Introduction
13.6.4 Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 AtlasMedx
13.7.1 AtlasMedx Company Details
13.7.2 AtlasMedx Business Overview and Its Total Revenue
13.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Introduction
13.7.4 AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
13.7.5 AtlasMedx Recent Development
13.8 Chordia Therapeutics
13.8.1 Chordia Therapeutics Company Details
13.8.2 Chordia Therapeutics Business Overview and Its Total Revenue
13.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
13.8.4 Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
13.8.5 Chordia Therapeutics Recent Development
13.9 IDEAYA Biosciences
13.9.1 IDEAYA Biosciences Company Details
13.9.2 IDEAYA Biosciences Business Overview and Its Total Revenue
13.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Introduction
13.9.4 IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
13.9.5 IDEAYA Biosciences Recent Development
13.10 Mission Therapeutics
13.10.1 Mission Therapeutics Company Details
13.10.2 Mission Therapeutics Business Overview and Its Total Revenue
13.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
13.10.4 Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
13.10.5 Mission Therapeutics Recent Development
13.11 Repare Therapeutics
10.11.1 Repare Therapeutics Company Details
10.11.2 Repare Therapeutics Business Overview and Its Total Revenue
10.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
10.11.4 Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
10.11.5 Repare Therapeutics Recent Development
13.12 Sierra Oncology
10.12.1 Sierra Oncology Company Details
10.12.2 Sierra Oncology Business Overview and Its Total Revenue
10.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Introduction
10.12.4 Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
10.12.5 Sierra Oncology Recent Development
13.13 SyntheX Labs
10.13.1 SyntheX Labs Company Details
10.13.2 SyntheX Labs Business Overview and Its Total Revenue
10.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Introduction
10.13.4 SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
10.13.5 SyntheX Labs Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Synthetic Lethality-based Drugs and Targets Key Market Segments
Table 2. Key Players Covered: Ranking by Synthetic Lethality-based Drugs and Targets Revenue
Table 3. Ranking of Global Top Synthetic Lethality-based Drugs and Targets Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monotherapy
Table 6. Key Players of Combination Therapy
Table 7. Global Synthetic Lethality-based Drugs and Targets Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Synthetic Lethality-based Drugs and Targets Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Synthetic Lethality-based Drugs and Targets Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2015-2020)
Table 11. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Synthetic Lethality-based Drugs and Targets Market Growth Strategy
Table 17. Main Points Interviewed from Key Synthetic Lethality-based Drugs and Targets Players
Table 18. Global Synthetic Lethality-based Drugs and Targets Revenue by Players (2015-2020) (Million US$)
Table 19. Global Synthetic Lethality-based Drugs and Targets Market Share by Players (2015-2020)
Table 20. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2019)
Table 21. Global Synthetic Lethality-based Drugs and Targets by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Synthetic Lethality-based Drugs and Targets Product Solution and Service
Table 24. Date of Enter into Synthetic Lethality-based Drugs and Targets Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020) (Million US$)
Table 27. Global Synthetic Lethality-based Drugs and Targets Market Size Share by Type (2015-2020)
Table 28. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2021-2026)
Table 29. Global Synthetic Lethality-based Drugs and Targets Market Size Share by Application (2015-2020)
Table 30. Global Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020) (Million US$)
Table 31. Global Synthetic Lethality-based Drugs and Targets Market Size Share by Application (2021-2026)
Table 32. North America Key Players Synthetic Lethality-based Drugs and Targets Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Synthetic Lethality-based Drugs and Targets Market Share (2019-2020)
Table 34. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020) (Million US$)
Table 35. North America Synthetic Lethality-based Drugs and Targets Market Share by Type (2015-2020)
Table 36. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020) (Million US$)
Table 37. North America Synthetic Lethality-based Drugs and Targets Market Share by Application (2015-2020)
Table 38. Europe Key Players Synthetic Lethality-based Drugs and Targets Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Synthetic Lethality-based Drugs and Targets Market Share (2019-2020)
Table 40. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Synthetic Lethality-based Drugs and Targets Market Share by Type (2015-2020)
Table 42. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Synthetic Lethality-based Drugs and Targets Market Share by Application (2015-2020)
Table 44. China Key Players Synthetic Lethality-based Drugs and Targets Revenue (2019-2020) (Million US$)
Table 45. China Key Players Synthetic Lethality-based Drugs and Targets Market Share (2019-2020)
Table 46. China Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020) (Million US$)
Table 47. China Synthetic Lethality-based Drugs and Targets Market Share by Type (2015-2020)
Table 48. China Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020) (Million US$)
Table 49. China Synthetic Lethality-based Drugs and Targets Market Share by Application (2015-2020)
Table 50. Japan Key Players Synthetic Lethality-based Drugs and Targets Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Synthetic Lethality-based Drugs and Targets Market Share (2019-2020)
Table 52. Japan Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Synthetic Lethality-based Drugs and Targets Market Share by Type (2015-2020)
Table 54. Japan Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Synthetic Lethality-based Drugs and Targets Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Synthetic Lethality-based Drugs and Targets Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Synthetic Lethality-based Drugs and Targets Market Share (2019-2020)
Table 58. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Share by Type (2015-2020)
Table 60. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Share by Application (2015-2020)
Table 62. India Key Players Synthetic Lethality-based Drugs and Targets Revenue (2019-2020) (Million US$)
Table 63. India Key Players Synthetic Lethality-based Drugs and Targets Market Share (2019-2020)
Table 64. India Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020) (Million US$)
Table 65. India Synthetic Lethality-based Drugs and Targets Market Share by Type (2015-2020)
Table 66. India Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020) (Million US$)
Table 67. India Synthetic Lethality-based Drugs and Targets Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Synthetic Lethality-based Drugs and Targets Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Synthetic Lethality-based Drugs and Targets Market Share (2019-2020)
Table 70. Central & South America Synthetic Lethality-based Drugs and Targets Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Synthetic Lethality-based Drugs and Targets Market Share by Type (2015-2020)
Table 72. Central & South America Synthetic Lethality-based Drugs and Targets Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Synthetic Lethality-based Drugs and Targets Market Share by Application (2015-2020)
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Product
Table 77. AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 78. AbbVie Recent Development
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Product
Table 82. AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 83. AstraZeneca Recent Development
Table 84. BeiGene Company Details
Table 85. BeiGene Business Overview
Table 86. BeiGene Product
Table 87. BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 88. BeiGene Recent Development
Table 89. Clovis Oncology Company Details
Table 90. Clovis Oncology Business Overview
Table 91. Clovis Oncology Product
Table 92. Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 93. Clovis Oncology Recent Development
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Product
Table 97. GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 98. GlaxoSmithKline Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Product
Table 102. Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 103. Pfizer Recent Development
Table 104. AtlasMedx Company Details
Table 105. AtlasMedx Business Overview
Table 106. AtlasMedx Product
Table 107. AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 108. AtlasMedx Recent Development
Table 109. Chordia Therapeutics Business Overview
Table 110. Chordia Therapeutics Product
Table 111. Chordia Therapeutics Company Details
Table 112. Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 113. Chordia Therapeutics Recent Development
Table 114. IDEAYA Biosciences Company Details
Table 115. IDEAYA Biosciences Business Overview
Table 116. IDEAYA Biosciences Product
Table 117. IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 118. IDEAYA Biosciences Recent Development
Table 119. Mission Therapeutics Company Details
Table 120. Mission Therapeutics Business Overview
Table 121. Mission Therapeutics Product
Table 122. Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 123. Mission Therapeutics Recent Development
Table 124. Repare Therapeutics Company Details
Table 125. Repare Therapeutics Business Overview
Table 126. Repare Therapeutics Product
Table 127. Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 128. Repare Therapeutics Recent Development
Table 129. Sierra Oncology Company Details
Table 130. Sierra Oncology Business Overview
Table 131. Sierra Oncology Product
Table 132. Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 133. Sierra Oncology Recent Development
Table 134. SyntheX Labs Company Details
Table 135. SyntheX Labs Business Overview
Table 136. SyntheX Labs Product
Table 137. SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2015-2020) (Million US$)
Table 138. SyntheX Labs Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Synthetic Lethality-based Drugs and Targets Market Share by Type: 2020 VS 2026
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2020 VS 2026
Figure 5. Medical Research Institution Case Studies
Figure 6. Hospital and Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Synthetic Lethality-based Drugs and Targets Report Years Considered
Figure 9. Global Synthetic Lethality-based Drugs and Targets Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions: 2020 VS 2026
Figure 11. Global Synthetic Lethality-based Drugs and Targets Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Synthetic Lethality-based Drugs and Targets Market Share by Players in 2019
Figure 14. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue in 2019
Figure 16. North America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. AbbVie Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 25. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. AstraZeneca Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 27. BeiGene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. BeiGene Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 29. Clovis Oncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Clovis Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 31. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. GlaxoSmithKline Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 33. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pfizer Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 35. AtlasMedx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AtlasMedx Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 37. Chordia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Chordia Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 39. IDEAYA Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. IDEAYA Biosciences Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 41. Mission Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Mission Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 43. Repare Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Repare Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 45. Sierra Oncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Sierra Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 47. SyntheX Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. SyntheX Labs Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs